IPSC
Price:
$1.02
Market Cap:
$86.73M
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106,...[Read more]
Industry
Biotechnology
IPO Date
2021-06-18
Stock Exchange
NASDAQ
Ticker
IPSC
According to Century Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -66.58%. This represents a change of 296.82% compared to the average of -16.78% of the last 4 quarters.
The mean historical ROE of Century Therapeutics, Inc. over the last ten years is 35.55%. The current -66.58% ROE has changed -287.29% with respect to the historical average. Over the past ten years (40 quarters), IPSC's ROE was at its highest in in the March 2021 quarter at 20.04%. The ROE was at its lowest in in the December 2023 quarter at -21.33%.
Average
35.55%
Median
-24.18%
Minimum
-73.98%
Maximum
267.78%
Discovering the peaks and valleys of Century Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 78.84%
Maximum Annual ROE = 267.78%
Minimum Annual Increase = -147.08%
Minimum Annual ROE = -73.98%
Year | ROE | Change |
---|---|---|
2023 | -73.98% | 71.05% |
2022 | -43.25% | 78.84% |
2021 | -24.18% | -147.08% |
2020 | 51.37% | -80.82% |
The current ROE of Century Therapeutics, Inc. (IPSC) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-47.14%
5-year avg
35.55%
10-year avg
35.55%
Century Therapeutics, Inc.’s ROE is greater than Edgewise Therapeutics, Inc. (-26.83%), greater than C4 Therapeutics, Inc. (-42.45%), greater than Mineralys Therapeutics, Inc. (-55.92%), greater than Cullinan Oncology, Inc. (-26.54%), greater than Passage Bio, Inc. (-72.53%), greater than Homology Medicines, Inc. (-100.91%), greater than Generation Bio Co. (-104.85%), greater than Stoke Therapeutics, Inc. (-54.45%), greater than Erasca, Inc. (-42.26%), greater than NGM Biopharmaceuticals, Inc. (-55.66%), greater than Keros Therapeutics, Inc. (-41.74%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), greater than Kezar Life Sciences, Inc. (-59.73%), greater than Nkarta, Inc. (-27.13%), greater than Theseus Pharmaceuticals, Inc. (-12.35%), greater than aTyr Pharma, Inc. (-56.83%), greater than Relay Therapeutics, Inc. (-45.75%), greater than Blueprint Medicines Corporation (-47.66%),
Company | ROE | Market cap |
---|---|---|
-26.83% | $2.81B | |
-42.45% | $268.94M | |
-55.92% | $626.59M | |
-26.54% | $708.63M | |
-72.53% | $40.15M | |
-100.91% | $3.02M | |
-104.85% | $71.47M | |
-54.45% | $594.82M | |
-42.26% | $735.09M | |
-55.66% | $128.53M | |
-41.74% | $681.74M | |
-62.68% | $432.51M | |
-59.73% | $47.06M | |
-27.13% | $160.89M | |
-12.35% | $181.50M | |
-56.83% | $131.12M | |
-45.75% | $703.85M | |
-47.66% | $5.72B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Century Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Century Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Century Therapeutics, Inc.'s ROE?
How is the ROE calculated for Century Therapeutics, Inc. (IPSC)?
What is the highest ROE for Century Therapeutics, Inc. (IPSC)?
What is the 3-year average ROE for Century Therapeutics, Inc. (IPSC)?
What is the 5-year average ROE for Century Therapeutics, Inc. (IPSC)?
How does the current ROE for Century Therapeutics, Inc. (IPSC) compare to its historical average?